Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function. Beyranvand Nejad E, Labrie C, van der Sluis TC, van Duikeren S, et al. Int J Cancer 2021;148:211-225.

Read + Share

Amedeo Smart

Independent Medical Education

Beyranvand Nejad E, Labrie C, van der Sluis TC, van Duikeren S, et al. Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function. Int J Cancer 2021;148:211-225.
PMID: 32875568